Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark B Jones

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Cell Reports|July 23, 2013
Innate immune-directed NF-κB signaling requires site-specific NEMO ubiquitinationJanice C Jun, Sylvia Kertesy, Mark B Jones, et al.
Plos One|July 26, 2017
T cell-intrinsic TLR2 stimulation promotes IL-10 expression and suppressive activity by CD45RbHi T cellsJanice C Jun, Mark B Jones, Douglas M Oswald, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2018
Plasma glycomics predict cardiovascular disease in patients with ART-controlled HIV infectionsDouglas M Oswald, Edward S Sim, Courtney Baker, et al.
Chemistry & Biology|December 23, 2006
Targeting glycosylation pathways and the cell cycle: sugar-dependent activity of butyrate-carbohydrate cancer prodrugsSrinivasa-Gopalan Sampathkumar, Mark B Jones, M Adam Meledeo, et al.
Glycoconjugate Journal|May 12, 2010
Development of delivery methods for carbohydrate-based drugs: controlled release of biologically-active short chain fatty acid-hexosamine analogsUdayanath Aich, M Adam Meledeo, Srinivasa-Gopalan Sampathkumar, et al.
Glycobiology|November 20, 2019
Identification of Tn antigen O-GalNAc-expressing glycoproteins in human carcinomas using novel anti-Tn recombinant antibodiesYasuyuki Matsumoto, Matthew R Kudelka, Melinda S Hanes, et al.
Molecular Therapy. Methods & Clinical Development|December 14, 2023
Erratum: Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicityJohn R Lydeard, Michelle I Lin, Huanying Gary Ge, et al.
Molecular Therapy. Methods & Clinical Development|November 29, 2023
Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicityJohn R Lydeard, Michelle I Lin, Huanying Gary Ge, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Cell Reports|July 23, 2013
Innate immune-directed NF-κB signaling requires site-specific NEMO ubiquitinationJanice C Jun, Sylvia Kertesy, Mark B Jones, et al.
Plos One|July 26, 2017
T cell-intrinsic TLR2 stimulation promotes IL-10 expression and suppressive activity by CD45RbHi T cellsJanice C Jun, Mark B Jones, Douglas M Oswald, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2018
Plasma glycomics predict cardiovascular disease in patients with ART-controlled HIV infectionsDouglas M Oswald, Edward S Sim, Courtney Baker, et al.
Chemistry & Biology|December 23, 2006
Targeting glycosylation pathways and the cell cycle: sugar-dependent activity of butyrate-carbohydrate cancer prodrugsSrinivasa-Gopalan Sampathkumar, Mark B Jones, M Adam Meledeo, et al.
Glycoconjugate Journal|May 12, 2010
Development of delivery methods for carbohydrate-based drugs: controlled release of biologically-active short chain fatty acid-hexosamine analogsUdayanath Aich, M Adam Meledeo, Srinivasa-Gopalan Sampathkumar, et al.
Glycobiology|November 20, 2019
Identification of Tn antigen O-GalNAc-expressing glycoproteins in human carcinomas using novel anti-Tn recombinant antibodiesYasuyuki Matsumoto, Matthew R Kudelka, Melinda S Hanes, et al.
Molecular Therapy. Methods & Clinical Development|December 14, 2023
Erratum: Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicityJohn R Lydeard, Michelle I Lin, Huanying Gary Ge, et al.
Molecular Therapy. Methods & Clinical Development|November 29, 2023
Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicityJohn R Lydeard, Michelle I Lin, Huanying Gary Ge, et al.
Pageof 3